News

View all
Thumbnail image for Four new medicines cleared for use on NHS Scotland

Four new medicines cleared for use on NHS Scotland

The Scottish Medicines Consortium has approved funding for four newly licensed medicines, expanding NHS treatments options in Scotland for ovarian cancer, lung cancer, urea cycle disorders and acute hereditary angioedema.

14th August 2018

Thumbnail image for Motif Bio’s antibiotic granted US priority review

Motif Bio’s antibiotic granted US priority review

US regulators have accepted for review a targeted, Gram-positive investigational antibiotic developed by UK biopharma Motif Bio for the treatment of acute bacterial skin and skin structure infections (ABSSSI).

14th August 2018

Web Exclusives

View all
Thumbnail image for Putting our heads together

Putting our heads together

NHS England’s assurance process provides a window of opportunity for pharma – but communication and joint working with the health service is key

Thumbnail image for The dementia dilemma

The dementia dilemma

The failure of several Alzheimer’s drug trials in the past year has dampened, but not destroyed, hopes for a cure

Thumbnail image for Health apps: The litmus test

Health apps: The litmus test

Our Mobile Health is on a mission to build confidence in digital health by assessing and curating high-quality health apps. CEO Julie Bretland  tells us what the company looks for in a good app and how digital  health can change the industry

Thought Leadership

View all

Webinars

View all

Designing Pharma organisations for success

Across all industries, people are changing the ways they engage with products, services, and brands. View more...

Wednesday, 28 September 2016 - 11:00 am
George Underwood
FREE - Listen again now - | VIEW NOW

Latest jobs

View all

Download our apps

Go to the App Store or Google Play and search for 'PharmaTimes' to download our free app.

Go to the App Store or Google Play and search for 'PharmaTimes' to download our free app.

Download